Data HIVNET

HIVnet is an interactive data tool from the HIV Research Network at the Agency for Healthcare Research and Quality. It provides researchers, policy makers and public health practitioners with information regarding the health care use of people with HIV. HIVnet focuses on outpatient and inpatient care patterns in large HIV health practices. HIV Dating Service will help you meet the right singles for HIV dating. If you have HIV and want to meet others in the same situation then join now and start living! Although placebo data was not included in other analyses of HIVNET 012 data, such as the results published in the 1999 and 2003 Lancet articles, data gathered from the placebo arms discontinued in February 1998 was used as a comparator in the assessment of hyperbilirubinemia in HIVNET 012 infants. Page 69 Share Cite. NIAID. Purpose Of The Database And Study Design: HIVNET was established in 1993 by the Division of AIDS (DAIDS), NIAID to be a multi-center, collaborative research network whose mission is to carry out HIV prevention efficacy trials.Its purpose was to evaluate the safety and effectiveness of promising interventions to prevent the transmission of HIV between sexual and/or needle-sharing ... HIV-NAT is affiliated with The Thai Red Cross AIDS Research Centre in Bangkok, Thailand, with the Kirby Institute for infection and immunity in society in Sydney, Australia, and with the Amsterdam Institute for Global Health and Development in Amsterdam, The Netherlands. HIVnet is an interactive data tool from the HIV Research Network at the Agency for Healthcare Research and Quality. It provides researchers, policy makers and public health practitioners with information regarding the health care use of people with HIV. HIVnet focuses on outpatient and inpatient care patterns in large HIV health practices. This is a retrospective data analysis of clinical and laboratory data collected prospectively on 128 HIV infected children in the HIVNET 012 trial. Methods TLC and CD4 cell % measurements were obtained at birth, 14 weeks and 12, 24, 36, 48, and 60 months of age and assessed with respect to risk of death within 12 months. Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Woody GE(1), Donnell D, Seage GR, Metzger D, Marmor M, Koblin BA, Buchbinder S, Gross M, Stone B, Judson FN. Author information: (1)University of PA/Philadelphia Veterans Affairs, Medical Center 19104, USA. [email protected] The data were collected from MSM recruited for participation in the Vaccine Preparedness Study (VPS) of the HIV Network for Prevention Trials (HIVNET). The VPS was a recent large multisite study that used a uniform protocol and risk assessment instruments and recruited MSM who reported any receptive or insertive (protected or unprotected) anal ... An examination of the data to support an extension of the indication for the use of NVP to include prevention of MTCT was recently begun. Although no evidence has been found that the conclusions of HIVNET 012 are invalid or that any trial participants were placed at an increased risk of harm, certain aspects of the collection of the primary ...

CTNPT 003 : Bone and renal outcomes in HIV-exposed infants with Dr. Jason Brophy Dr. Rupert Kaul on probiotic supplements for gut immune health: CTNPT 022 Dr. Ostrowski's pilot study: Therapeutic HIV vaccine with early HAART treatment initiation CTNPT 011: HIV and Syphilis with Dr. Paul MacPherson CTN 247 Canadian cohort of HIV+ slow

Total Lymphocyte Count: not a surrogate marker for risk of ...

  1. CTNPT 003 : Bone and renal outcomes in HIV-exposed infants with Dr. Jason Brophy
  2. Dr. Rupert Kaul on probiotic supplements for gut immune health: CTNPT 022
  3. Dr. Ostrowski's pilot study: Therapeutic HIV vaccine with early HAART treatment initiation
  4. CTNPT 011: HIV and Syphilis with Dr. Paul MacPherson
  5. CTN 247 Canadian cohort of HIV+ slow

Bone and renal outcomes in HIV-exposed uninfected infants with perinatal exposure to tenofovir Dr. Jason Brophy explains this study. About the study This pilot study will gather data to help ... This CTN pilot study will gather data to help determine appropriate penicillin dosages for treating syphilis. The study researchers will also examine the extent to which the standard treatment of ... This pilot trial will gather data to see if prescribing probiotic supplements can improve the immune function and gut health in men starting antiretroviral therapy and immune non-responders ... A study of host and viral factors associated with disease progression in long term HIV infected subjects Principal Investigator Dr. Cécile Tremblay explains her study. About the study: The ... This proof-of-concept pilot study (CTNPT 020) will test to see if a therapeutic DNA vaccine delivered via electroporation (an electrical pulse) can lead to a lessening of HIV viral reservoirs and ...